Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
The penetration of aztreonam into cerebrospinal fluid was 7 to 15% and 9 to 25%, respectively, in experimental Haemophilus influenzae type b and Escherichia coli K1 meningitis. Aztreonam was effective in reducing the number of organisms in cerebrospinal fluid after single-dose and continuous infusio...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1985
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180117/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3890733/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.655 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
